Biomimetic Nanomotors for Deep Ischemia Penetration and Ferroptosis Inhibition in Neuroprotective Therapy of Ischemic Stroke
Advanced Materials · 2025-01 · 37 (3)
DOI: 10.1002/adma.202409176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 26.11.2024. Verfasst von Rui Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery (Ministry of Education), Shanghai, 201203, C…. Hauptthemen laut MEDLINE: Ferroptosis, Neuroprotective Agents, Ischemic Stroke, Biomimetic Materials. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Themen: Schlaganfall
Abstract (Originalsprache)
Nerve injury represents the primary reason of mortality and disability in ischemic stroke, but effective drug delivery to the region of cerebral ischemia and hypoxia poses a significant challenge in neuroprotective treatment. To address these clinical challenges, a biomimetic nanomotor, Pt@LF is designed, to facilitate deep delivery of neuroprotective agents and inhibit ferroptosis in ischemic stroke. Pt@LF traverses the blood‐brain barrier (BBB) and penetrates into deep cerebral ischemic‐hypoxic areas due to the active targeting capacity of apo‐lactoferrin (Apo‐LF) and the self‐propelling motion properties of nanomotors. Subsequently, Pt@LF loosens thrombus and alleviates the “no reflow” phenomenon via mechanical thrombolysis. Thanks to the various enzyme‐like abilities and multi‐target ferroptosis inhibition capability, Pt@LF ameliorates the inflammatory microenvironment and rescues dying neurons. In conclusion, Pt@LF demonstrates efficiently deep penetration and neuroprotective effects in vitro and vivo. And this study provides a promising therapeutic platform for the treatment of ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery (Ministry of Education), Shanghai, 201203, China.
- Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (Ministry of Education), Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, 200 433, China.
- Department of Radiology, Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine, Shanghai, 200 081, China.
- Department of Neurology, Minhang Hospital, Fudan University, Shanghai, 201 102, China.
- Institute of Healthy Yangtze River Delta, Shanghai Jiao Tong University, Shanghai, 200 030, China.
- Quzhou Fudan Institute, Quzhou, 324 002, China.
ORCID-Profile: Xianyi Sha
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Wang, R., Nie, W., Yan, X., Luo, K., Zhang, Q., Wang, T., Lu, E., Chen, Y., Luo, Y., Zhang, Z., Wang, H., Zhao, J., & Sha, X. (2025). Biomimetic Nanomotors for Deep Ischemia Penetration and Ferroptosis Inhibition in Neuroprotective Therapy of Ischemic Stroke. Advanced Materials, 37(3). https://doi.org/10.1002/adma.202409176
Vancouver
Wang R, Nie W, Yan X, Luo K, Zhang Q, Wang T, et al. Biomimetic Nanomotors for Deep Ischemia Penetration and Ferroptosis Inhibition in Neuroprotective Therapy of Ischemic Stroke. Advanced Materials. 2025;37(3). doi:10.1002/adma.202409176
BibTeX
@article{Wang2025,
author = {Wang, Rui and Nie, Weimin and Yan, Xin and Luo, Kuankuan and Zhang, Qi and Wang, Tao and Lu, Enhao and Chen, Yiting and Luo, Yu and Zhang, Zhiwen and Wang, He and Zhao, Jing and Sha, Xianyi},
title = {Biomimetic Nanomotors for Deep Ischemia Penetration and Ferroptosis Inhibition in Neuroprotective Therapy of Ischemic Stroke},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {3},
doi = {10.1002/adma.202409176}
}
EUVIMED